Mechanism of reducing platelet activity by percutaneous transluminal mitral valvuloplasty in patients with rheumatic mitral stenosis

Chest

Volumn 125, Issue 5, 2004, Pages 1629-1634

  Chen, Mien Cheng ^a   Wu, Chiung Jen ^a   Chang, Hsueh Wen ^b   Yip, Hon Kan ^a   Chen, Yen Hsun ^a   Cheng, Cheng I ^a   Chai, Han Tan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Mitral stenosis; Platelet; Valvulopksty

Indexed keywords

PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM PRESSURE; HUMAN; LUNG ARTERY PRESSURE; MALE; MITRAL VALVE; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; THROMBOCYTE ACTIVATION; TRANSLUMINAL VALVULOPLASTY; VENOUS BLOOD;

EID: 2442547265     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.5.1629     Document Type: Article

References (33)

1. Kunishima S, Hattor M, Kobayashi S, et al. Activation and destruction of platelets in patients with rheumatic heart disease. Eur Heart J 1994; 15:335-338
2. Steele PP, Weily HS, Davies H, et al. Platelet survival in patients with rheumatic heart disease. N Engl J Med 1974; 290:537-539
3. Kataoka H, Yano S, Tamura A, et al. Hemostatic changes induced by percutaneous mitral valvuloplasty. Am Heart J 1993; 125:777-782
4. Zaki A, Salama M, Masry ME, et al. Immediate effect of balloon valvuloplasty on hemostatic changes in mitral stenosis. Am J Cardiol 2000; 85:370-375
5. Kaplan KL, Owen J. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57:199-202
6. Stenberg PE, Mcever RP, Shuman MA, et al. A platelet alpha-granule membrane protein (CMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101:880-886
7. Berman CL, Yeo EL, Wencel-Drake JD, et al. A platelet alpha-granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest 1986; 78: 130-137
8. Cox D. Methods for monitoring platelet function. Am Heart J 1998; 135:S161-S169
9. Chen MC, Wu CJ, Yip HK, et al. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry. Chest 2003; 124:1663-1669
10. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation 1979; 60:1096-1104
11. Chen C, Wang Y, Guo B, et al. Reliability of the Doppler pressure half-time method for assessing effects of percutaneous mitral balloon valvuloplasty. J Am Coll Cardiol 1989; 13:1309-1313
12. Hung JS, Chern MS, Wu JJ, et al. Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy. Am J Cardiol 1991; 67:854-862
13. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989; 79:101-106
14. Modderman PW. New clusters: CD29/CDw49, CD47, CD51, CD55 and CD61. In: Knapp W, Dörken B, Gilks WR, et al, eds. Leucocyte typing IV, white cell differentiation antigens. Oxford, UK: Oxford University Press, 1989; 1017-1019
15. Abrams CS, Ellison N, Budzynski AZ, et al. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75:128-138
16. Cahill M, Macey M, Newland A. Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P-selectin [CD62] and GP53 [CD63] Br J Haematol 1993; 84:527-529
17. Ritchie JL, Alexander HD, Rea IM. Flow cytometry analysis of platelet P-selectin expression in whole blood-methodological considerations. Clin Lab Haematol 2000; 22:359-363
18. Smith RL, Blick EF, Coalson J, et al. Thrombus production by turbulence. J Appl Physiol 1972; 32:261-264
19. Stein PD, Sabbah HN. Measured turbulence and its effect on thrombus formation. Circ Res 1974; 35:608-614
20. Stein PD, Sabbah HN. Turbulence blood flow in the ascending aorta of humans with normal and diseased aortic valves. Circ Res 1976; 39:58-65
21. YU SK, Latour JC, Marchandise B, et al. Shear stress-induced changes in platelet reactivity. Thromb Haemost 1978; 40: 551-560
22. Reyes VP, Raju S, Wynne J, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med 1994; 331:961-967
23. Chiang CW, Lo SK, Kuo CT, et al. Noninvasive predictors of systemic embolism in mitral stenosis: an echocardiographic and clinical study of 500 patients. Chest 1994; 106:396-399
24. Szekely P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964; 1:1209-1212
25. Fleming HA, Bailey SM. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 1995; 47:599-604
26. Neilson GH, Galea EG, Hossack KF. Thromboembolic complications of mitral valve disease. Aust N Z J Med 1978; 8:372-376
27. Daniel WG, Nellessen U, Schroder E, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988; 11:1204-1211
28. Rittoo D, Sutherland GR, Curie P, et al. A prospective study of left atrial spontaneous echo contrast and thrombus in 100 consecutive patients referred for balloon dilatation of the mitral valve. J Am Soc Echocardiogr 1994; 7:516-527
29. Jafri SM, Caceres L, Rosman HS, et al. Activation of the coagulation system in women with mitral stenosis and sinus rhythm. Am J Cardiol 1992; 70:1217-1219
30. Yamamoto K, Ikeda U, Seino Y, et al. Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol 1995; 25:107-112
31. Chiang CW, Lo SK, Ko YS, et al. Predictors of systemic embolism in patients with mitral stenosis: a prospective study. Ann Intern Med 1998; 128:885-889
32. Peverill RE, Harper RW, Gan TE, et al. Effects of balloon mitral valvuloplasty on systemic and regional left atrial level of prothrombin fragment 1+2 in mitral stenosis. Clin Sci (Lond) 2000; 99:269-276
33. Klein B, Faridi A, von Tempelhoff GF, et al. A whole blood flow cytometric determination of platelet activation by unfractionated and low molecule weight heparin in vitro. Thromb Res 2002; 108:291-296